Chloroquine enhances Epstein–Barr virus expression

Article metrics

Abstract

AFRICAN Burkitt's lymphoma (BL) is a malignant tumour of children most common in areas having holoendemic malaria1,2. It occurs with a particularly high frequency in certain areas of Africa3, with sporadic cases in other areas including Europe and North America4–7. Malaria has been shown to have immunosuppressive effects8,9, and chronic malaria, in particular, causes repeated stimulation of the immune response to infections with plasmodia. It has also been proposed that the immunosuppressive action of malarial drugs may make the immune system more susceptible to cancer and may contribute to BL development. Chloroquine is widely used as an antimalarial agent and also in the therapy of connective tissue diseases10,11. It is thought to act by forming molecular complexes with plasmodial DNA, causing inhibition of plasmodial DNA synthesis12–14. It has been suggested that chloroquine may play a part in the development of BL15. Another factor thought to be involved in the aetiology of the African form of BL is the Epstein–Barr virus. Virtually all BLs are EBV genome-carrying tumours and patients have high titres of antibody against EBV16,17 The most widely proposed hypothesis is that BL is due to EBV-induced malignant transformation of thymus-independent B lymphocytes17,18. It has been shown in vitro that EBV can induce transformation of resting human and simian lymphocytes which become established as permanent lines19,20. Almost all the cells in these lines contain EBNA (the EBV-induced nuclear antigen) and carry multiple copies of EBV DNA21,22. It has also been shown that EBV can induce lymphomas in experimentally infected monkeys23. However, the failure of EBV infection to have serious adverse effects in the great majority of humans indicates that interaction with some other factor, such as malaria or antimalarial drugs, must be involved in BL pathogenesis. We report here studies on the effect of chloroquine on the expression of EBV antigens. The data obtained indicate that chloroquine can activate the EBV cycle and the expression of EBV antigens.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Burkitt, D. P. Int. Rev. exp. Path 2, 67–138 (1963).

  2. 2

    Klein, G. in The Herpes Viruses (ed. Kaplan, A.) 521–555 (Academic, New York, 1973).

  3. 3

    Burkitt, D. Br. J. Surg. 46, 218–223 (1958); Nature 194, 232–234 (1962).

  4. 4

    Pagano, J. S., Huang, C. H. & Levine, P. New Engl. J. Med. 289, 1395–1399 (1973).

  5. 5

    Levine, P. H. et al. Ann. intern. Med. 83, 31–36 (1975).

  6. 6

    Ziegler, J. L. New Engl. J. Med. 297, 75–80 (1977).

  7. 7

    Judson, S. C. & Henle, G. New Engl. J. Med. 297, 464–468 (1977).

  8. 8

    Salaman, M. H., Wedderbum, N. & Bruce-Chwatt, L. J. J. gen. Microbiol. 59, 383 (1969).

  9. 9

    Gazayerli, M. Bull. Int. Acad. Path. 4, 37 (1963).

  10. 10

    Goodman, L. S. & Gilman, A. in The Pharmacological basis of Therapeutics, 5th edn, 1049–1053 (Macmillan, London, 1975).

  11. 11

    Coatney, G. R. Am. J. trop. Med. Hyg. 12, 121–128 (1963).

  12. 12

    Parker, F. S. & Irvin, J. L. J. biol. Chem. 199, 897 (1952).

  13. 13

    Cohen, S. N. & Yielding, K. L. Proc. natn. Acad. Sci. U.S.A. 54, 521–527 (1965).

  14. 14

    Karmali, R., Schiller, P. W. & Horrobin, D. F. Prostaglandins 12, 463–464 (1976).

  15. 15

    Sadoff, L. Lancet ii, 1262–1263 (1973).

  16. 16

    Henle, G. et al. J. natn. Cancer Inst. 43, 1147–1157 (1969).

  17. 17

    Klein, G. New Engl. J. Med. 293, 1353–1357, 1975.

  18. 18

    Olweny, C. L. M. et al. J. natn. Cancer Inst. 58, 1191–1196 (1977).

  19. 19

    Pope, J. H., Horne, M. K. & Scott, W. Int. J. Cancer 3, 857–866 (1968).

  20. 20

    Miller, G., Shope, T., Lisco, H., Stit, D. & Lipman, M. Proc. natn. Acad. Sci. U.S.A. 69, 383–387 (1972).

  21. 21

    Lindahl, T. et al. Int. J. Cancer 13, 764–772 (1974).

  22. 22

    Menezes, J., Leibold, W. & Klein, G. Expl Cell Res. 92, 478–484 (1975).

  23. 23

    Shope, T., Dechario, D. & Miller, G. Proc. natn. Acad. Sci. U.S.A. 70, 2487–2491 (1973).

  24. 24

    Pulvertaft, R. J. V. J. clin. Path. 18, 261–273 (1965).

  25. 25

    Hinuma, Y. & Grace, J. T. Proc. Soc. exp. Biol. Med. 124, 107–111 (1967).

  26. 26

    Covell, G., Coatney, G. R., Field, J. W. & Singh, J. Monograph Ser. W.H.O. 27 (1955).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

KARMALI, R., HORROBIN, D., MENEZES, J. et al. Chloroquine enhances Epstein–Barr virus expression. Nature 275, 444–445 (1978) doi:10.1038/275444a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.